Table 3. Prevalence of Aldehyde Dehydrogenase 1 (ALDH1) Expression in Stroma, Epithelial Cells in Different Subtypes of Breast Cancers.
Subtype | ALDH1-Negative N (%) | ALDH1-Positive N (%) |
---|---|---|
Stroma | ||
HER2− and ER− and PR− | 30 (51.7) | 28 (48.3) |
HER2+ and ER− and/or PR+/PR− | 13 (72.2) | 5 (27.8) |
HER2− and ER+ and/or PR+/PR− | 13 (68.4) | 6 (31.6) |
HER2+ and ER+ and PR+ | 4 (50.0) | 4 (50.0) |
Epithelial | ||
HER2− and ER− and PR− | 27 (46.6) | 31 (53.4) |
HER2+ and ER− and/or PR+/PR− | 13 (72.2) | 5 (27.8) |
HER2− and ER+ and/or PR+/PR− | 13 (68.4) | 6 (31.6) |
HER2+ and ER+ and PR+ | 4 (50.0) | 4 (50.0) |
Abbreviations: ER, estrogen receptor; HER2, human epidermal growth factor receptor 2/glioblastoma; PR, progesterone receptor.